tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

JAZZ Stock Latest News

Jazz Pharmaceuticals’ Promising Study on Zanidatamab for HER2-positive Breast Cancer
Company AnnouncementsJazz Pharmaceuticals’ Promising Study on Zanidatamab for HER2-positive Breast Cancer
2d ago
JAZZ
Jazz Pharmaceuticals’ New Study on Zanidatamab: A Potential Game-Changer in Breast Cancer Treatment?
PremiumCompany Announcements
Jazz Pharmaceuticals’ New Study on Zanidatamab: A Potential Game-Changer in Breast Cancer Treatment?
4d ago
JAZZ
Jazz Pharmaceuticals says EC grants marketing authorization for Ziihera
PremiumThe Fly
Jazz Pharmaceuticals says EC grants marketing authorization for Ziihera
6d ago
JAZZ
Jazz Pharmaceuticals’ Pregnancy Surveillance Study: A Key Update for Investors
PremiumCompany Announcements
Jazz Pharmaceuticals’ Pregnancy Surveillance Study: A Key Update for Investors
6d ago
JAZZ
Jazz Pharmaceuticals Completes Key Study on Zepzelca for SCLC
PremiumCompany Announcements
Jazz Pharmaceuticals Completes Key Study on Zepzelca for SCLC
6d ago
JAZZ
Avadel announces appeals court decision upholding FDA approval of LUMRYZ
PremiumThe FlyAvadel announces appeals court decision upholding FDA approval of LUMRYZ
7d ago
AVDL
JAZZ
Jazz Pharmaceuticals and BeiGene’s Promising Phase 3 Study for Advanced Gastric and Esophageal Cancers
Premium
Company Announcements
Jazz Pharmaceuticals and BeiGene’s Promising Phase 3 Study for Advanced Gastric and Esophageal Cancers
9d ago
ONC
JAZZ
Jazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in HER2 Cancer Treatment
Premium
Company Announcements
Jazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in HER2 Cancer Treatment
9d ago
JAZZ
Jazz Pharmaceuticals’ Epidiolex Study: A Potential Game-Changer for TSC Treatment?
PremiumCompany Announcements
Jazz Pharmaceuticals’ Epidiolex Study: A Potential Game-Changer for TSC Treatment?
10d ago
JAZZ
Jazz Pharmaceuticals: Promising Developments in ES-SCLC and Anticipated Stock Growth
PremiumRatings
Jazz Pharmaceuticals: Promising Developments in ES-SCLC and Anticipated Stock Growth
24d ago
JAZZ
Buy Rating for Jazz Pharmaceuticals: Promising Clinical Trial Results and Market Potential of Zepzelca
PremiumRatings
Buy Rating for Jazz Pharmaceuticals: Promising Clinical Trial Results and Market Potential of Zepzelca
26d ago
JAZZ
Jazz Pharmaceuticals: Strategic Expansion of Zepzelca Drives Buy Rating Amid Growth Potential
PremiumRatings
Jazz Pharmaceuticals: Strategic Expansion of Zepzelca Drives Buy Rating Amid Growth Potential
26d ago
JAZZ
Jazz Pharmaceuticals: FDA accepts sNDA for Zepzelca/ Atezolizumab combo
PremiumThe FlyJazz Pharmaceuticals: FDA accepts sNDA for Zepzelca/ Atezolizumab combo
27d ago
JAZZ
Jazz Pharmaceuticals presents late-breaking phase 4 data showcasing Xywav
Premium
The Fly
Jazz Pharmaceuticals presents late-breaking phase 4 data showcasing Xywav
27d ago
JAZZ
Jazz Pharmaceuticals: Promising Developments and Positive Data Reinforce Buy Rating
Premium
Ratings
Jazz Pharmaceuticals: Promising Developments and Positive Data Reinforce Buy Rating
1M ago
JAZZ
Jazz Pharmaceuticals announces ‘positive’ results from Phase 3 IMforte study
PremiumThe Fly
Jazz Pharmaceuticals announces ‘positive’ results from Phase 3 IMforte study
1M ago
JAZZ
Jazz Pharmaceuticals reports 15.2 months median PFS in Phase 2 trial
PremiumThe Fly
Jazz Pharmaceuticals reports 15.2 months median PFS in Phase 2 trial
1M ago
JAZZ
Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board
PremiumStock Analysis & Ideas
Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board
2M ago
WGS
BLDR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PTN
BOLT
Optimistic Buy Rating for Jazz Pharmaceuticals Amidst Short-term Challenges and Long-term Growth Potential
PremiumRatingsOptimistic Buy Rating for Jazz Pharmaceuticals Amidst Short-term Challenges and Long-term Growth Potential
2M ago
JAZZ
Jazz Pharmaceuticals Balances Growth and Challenges in Earnings Call
Premium
Company Announcements
Jazz Pharmaceuticals Balances Growth and Challenges in Earnings Call
2M ago
JAZZ
Jazz Pharmaceuticals price target lowered to $172 from $182 at RBC Capital
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $172 from $182 at RBC Capital
2M ago
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >